— Most panelists favored a bivalent vaccine containing a vaccine against the BA.4/BA.5 strains by Joyce Frieden | June 28, 2022 An FDA advisory committee voted 19-2 on Tuesday to recommend use of an Omicron-specific component in a future COVID-19 vaccine booster. “We really do need vaccines that provide broader protection against variants that have not yet emerged,” said Melinda Wharton, MD, MPH, associate director of vaccine policy at the CDC, at a remote meeting of the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC).… Read the rest